Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.07 USD | +0.04% | -0.39% | -8.84% |
May. 02 | Enovis Q1 Shares Fall Following Q1 Results | MT |
May. 02 | Transcript : Enovis Corporation, Q1 2024 Earnings Call, May 02, 2024 |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The company appears to be poorly valued given its net asset value.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- Low profitability weakens the company.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.84% | 2.8B | B- | ||
+10.39% | 126B | A- | ||
-6.86% | 10.96B | A- | ||
+2.52% | 8.97B | C | ||
+38.96% | 5.56B | B+ | ||
-17.50% | 4.99B | C | ||
+8.36% | 3.44B | C- | ||
-7.52% | 2.18B | - | - | |
-3.00% | 2.16B | - | ||
-21.88% | 1.82B | - | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ENOV Stock
- Ratings Enovis Corporation